{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:34:05Z","timestamp":1790674445344,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2011-29507"],"award-info":[{"award-number":["SAF2011-29507"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"RETICS","award":["R006\/0010\/0006"],"award-info":[{"award-number":["R006\/0010\/0006"]}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2009SGR-00326"],"award-info":[{"award-number":["2009SGR-00326"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.nbd.2015.09.001","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T14:58:09Z","timestamp":1442069889000},"page":"22-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Prostaglandin E2 EP2 activation reduces memory decline in R6\/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity"],"prefix":"10.1016","volume":"95","author":[{"given":"Marta","family":"Anglada-Huguet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vidal-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Garc\u00eda-D\u00edaz Barriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Xifr\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.09.001_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0079-6123(07)00006-4","article-title":"Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase","volume":"169","author":"Abel","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2015.09.001_bb0010","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1089\/neu.2006.23.1895","article-title":"Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity","volume":"23","author":"Ahmad","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.nbd.2015.09.001_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nbd.2006.01.010","article-title":"Prostaglandin E2 and BDNF levels in rat hippocampus are negatively correlated with status epilepticus severity: no impact on survival of seizure-generated neurons","volume":"23","author":"Ajmone-Cat","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.09.001_bb0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0306-4522(89)90424-7","article-title":"The three-dimensional organization of the hippocampal formation: a review of anatomical data","volume":"31","author":"Amaral","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.09.001_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(07)63001-5","article-title":"The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies)","volume":"163","author":"Amaral","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2015.09.001_bb0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.2012.07711.x","article-title":"Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease","volume":"121","author":"Anglada-Huguet","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.09.001_bb0035","article-title":"Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6\/1 mouse model of Huntington's disease","author":"Anglada-Huguet","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ana.20179","article-title":"PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis","volume":"56","author":"Bilak","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"Binder","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.nbd.2015.09.001_bb0050","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI27607","article-title":"Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase","volume":"116","author":"Borrell-Pages","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2015.09.001_bb0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1146\/annurev.pharmtox.41.1.661","article-title":"Prostanoid receptors: subtypes and signaling","volume":"41","author":"Breyer","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/JCI74809","article-title":"Neurotrophin receptor p75NTR mediates Huntington's disease-associated synaptic and memory dysfunction","author":"Brito","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2015.09.001_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainresbull.2011.10.002","article-title":"Comparative analysis of pathology and behavioural phenotypes in mouse models of Huntington's disease","volume":"88","author":"Brooks","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2015.09.001_bb0070","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2008.05.111","article-title":"Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress","volume":"441","author":"Carrasco","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.09.001_bb0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.expneurol.2012.06.033","article-title":"Age-dependent decline of motor neocortex but not hippocampal performance in heterozygous BDNF mice correlates with a decrease of cortical PSD-95 but an increase of hippocampal TrkB levels","volume":"237","author":"Carreton","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0085","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1152\/jn.2002.87.6.2851","article-title":"Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity","volume":"87","author":"Chen","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1326-6-81","article-title":"Dantrolene is neuroprotective in Huntington's disease transgenic mouse model","volume":"6","author":"Chen","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2015.09.001_bb0095","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","article-title":"The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system","volume":"18","author":"Chiang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.09.001_bb0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.nbd.2006.09.006","article-title":"Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity","volume":"25","author":"DeMarch","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.09.001_bb0105","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/j.1460-9568.2005.04427.x","article-title":"Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure","volume":"22","author":"Echeverria","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0110","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.09.001_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.09.001_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064037","article-title":"Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington's disease","volume":"8","author":"Giampa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.09.001_bb0130","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","article-title":"Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression","volume":"158","author":"Giralt","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.09.001_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1326-6-71","article-title":"Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction","volume":"6","author":"Giralt","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2015.09.001_bb0140","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","article-title":"Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity","volume":"21","author":"Giralt","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.09.001_bb0145","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hipo.22128","article-title":"PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model","volume":"23","author":"Giralt","year":"2013","journal-title":"Hippocampus"},{"key":"10.1016\/j.nbd.2015.09.001_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2015.09.001_bb0155","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's disease collaborative research group","volume":"72","author":"HDCRG","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.09.001_bb0160","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/nn927","article-title":"BDNF release from single cells elicits local dendritic growth in nearby neurons","volume":"5","author":"Horch","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuint.2009.01.018","article-title":"Activation of EP2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF","volume":"54","author":"Hutchinson","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2015.09.001_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddg002","article-title":"Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein","volume":"12","author":"Jiang","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.09.001_bb0175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-4-2","article-title":"Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein","volume":"4","author":"Jin","year":"2007","journal-title":"J. Neuroinflammation"},{"issue":"Pt 5","key":"10.1016\/j.nbd.2015.09.001_bb0180","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","article-title":"Executive and mnemonic functions in early Huntington's disease","volume":"119","author":"Lawrence","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.09.001_bb0185","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1523\/JNEUROSCI.3591-05.2005","article-title":"Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease","volume":"25","author":"Liang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0190","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.21437","article-title":"The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis","volume":"64","author":"Liang","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0195","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1212\/WNL.0b013e3181ec805b","article-title":"Before chorea: pre-Huntington mild cognitive impairment","volume":"75","author":"Lichter","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.09.001_bb0200","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ana.20461","article-title":"Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia","volume":"57","author":"Liu","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrn1726","article-title":"The yin and yang of neurotrophin action","volume":"6","author":"Lu","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0210","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrn3505","article-title":"BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases","volume":"14","author":"Lu","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0215","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.09.001_bb0220","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0225","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.09.001_bb0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration","volume":"31","author":"Mantamadiotis","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2015.09.001_bb0235","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1523\/JNEUROSCI.4485-03.2004","article-title":"Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia","volume":"24","author":"McCullough","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0240","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","article-title":"Excitotoxicity: bridge to various triggers in neurodegenerative disorders","volume":"698","author":"Mehta","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0245","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease","volume":"33","author":"Milnerwood","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0250","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/hmg\/ddl092","article-title":"Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease","volume":"15","author":"Milnerwood","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.09.001_bb0255","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington's disease","volume":"117","author":"Moller","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2015.09.001_bb0260","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1471-4159.2002.01157.x","article-title":"Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent","volume":"83","author":"Montine","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.09.001_bb0265","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0270","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene\u2013environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice","volume":"29","author":"Nithianantharajah","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.09.001_bb0275","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.09.001_bb0280","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.3493-03.2004","article-title":"CRE-mediated transcription is increased in Huntington's disease transgenic mice","volume":"24","author":"Obrietan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0285","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2015.09.001_bb0290","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nn0310-275","article-title":"Myelin maintenance: axonal support required","volume":"13","author":"Popko","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0295","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lfs.2003.09.031","article-title":"EP2 and EP4 prostanoid receptor signaling","volume":"74","author":"Regan","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0300","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.neuron.2009.08.014","article-title":"NCS-1 in the dentate gyrus promotes exploration, synaptic plasticity, and rapid acquisition of spatial memory","volume":"63","author":"Saab","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.09.001_bb0305","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1523\/JNEUROSCI.2392-05.2005","article-title":"Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor","volume":"25","author":"Sang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0310","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2009.01.016","article-title":"Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor","volume":"217","author":"Savonenko","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0315","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.biopsych.2008.12.026","article-title":"Abnormal motor cortex excitability in preclinical and very early Huntington's disease","volume":"65","author":"Schippling","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2015.09.001_bb0320","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1046\/j.1460-9568.2003.02643.x","article-title":"Deficits in spatial learning and synaptic plasticity induced by the rapid and competitive broad-spectrum cyclooxygenase inhibitor ibuprofen are reversed by increasing endogenous brain-derived neurotrophic factor","volume":"17","author":"Shaw","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainres.2005.01.035","article-title":"Cyclooxygenase inhibition attenuates endotoxin-induced spatial learning deficits, but not an endotoxin-induced blockade of long-term potentiation","volume":"1038","author":"Shaw","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.09.001_bb0330","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.09.001_bb0335","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nbd.2010.10.015","article-title":"Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6\/2 mice","volume":"41","author":"Simmons","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.09.001_bb0340","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.09.001_bb0345","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2015.09.001_bb0350","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.09.001_bb0355","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-5793(04)00246-7","article-title":"Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures","volume":"562","author":"Toyomoto","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2015.09.001_bb0360","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","article-title":"Impaired synaptic plasticity in mice carrying the Huntington's disease mutation","volume":"8","author":"Usdin","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.09.001_bb0365","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0370","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","article-title":"Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease","volume":"10","author":"Wyttenbach","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.09.001_bb0375","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.pnpbp.2009.03.036","article-title":"Dentate gyrus and spatial behaviour","volume":"33","author":"Xavier","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2015.09.001_bb0380","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0385","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1460-9568.2005.03935.x","article-title":"Brief exposure to NMDA produces long-term protection of cerebellar granule cells from apoptosis","volume":"21","author":"Xifro","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0390","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2009.08.012","article-title":"Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity","volume":"36","author":"Xifro","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.09.001_bb0395","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.conb.2011.03.001","article-title":"PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) and synaptic plasticity","volume":"21","author":"Xu","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0400","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.09.001_bb0405","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1471-4159.2008.05766.x","article-title":"Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor","volume":"108","author":"Yang","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.09.001_bb0410","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1046\/j.1460-9568.1999.00682.x","article-title":"Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation","volume":"11","author":"Zhang","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2015.09.001_bb0415","doi-asserted-by":"crossref","first-page":"22460","DOI":"10.1074\/jbc.M702439200","article-title":"Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6","volume":"282","author":"Zhang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.09.001_bb0420","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0425","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0430","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2015.09.001_bb0435","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2015.09.001_bb0440","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115300474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115300474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:36:27Z","timestamp":1772048187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115300474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":88,"alternative-id":["S0969996115300474"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.09.001","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostaglandin E2 EP2 activation reduces memory decline in R6\/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}